Search research articles
Contact Us
Filters
Showing results (101-110 of 156) with videos related to
Page
of 16
Sort By:
Clinical Practice and Epidemiology in Mental Health : CP & EMH
|
December 9, 2010
Psychometric Attributes of the DISC Predictive Scales
Esther Cubo, Sara Sáez Velasco, Vanesa Delgado Benito, et al.
Journal of Parkinson'S Disease
|
January 2, 2022
Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel
Norbert Kovács, Lars Bergmann, Marieta Anca-Herschkovitsch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 8, 2005
Transcultural comparison of psychogenic movement disorders
Esther Cubo, Vanessa K Hinson, Christopher G Goetz, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
July 16, 2016
Spanish Validation of the Problem Behaviors Assessment-Short (PBA-s) for Huntington's Disease
Jesús M Ruiz-Idiago, Misericordia Floriach, Cèlia Mareca, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations
Tiago A Mestre, Monica Busse, Aileen M Davis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 24, 2018
Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life
Tiago A Mestre, Noelle E Carlozzi, Aileen K Ho, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 21, 2022
Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington's disease
Miriam Saiz-Rodríguez, Cecilia Gil-Polo, Mónica Diez-Fairen, et al.
Movement Disorders Clinical Practice
|
October 11, 2021
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease
David G Standaert, Jason Aldred, Marieta Anca-Herschkovitsch, et al.
Plos One
|
December 21, 2021
Adopting a multidisciplinary telemedicine intervention for fall prevention in Parkinson's disease. Protocol for a longitudinal, randomized clinical trial
Esther Cubo, Alvaro Garcia-Bustillo, Alvar Arnaiz-Gonzalez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 15, 2016
Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations
Tiago A Mestre, Erik van Duijn, Aileen M Davis, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 156) with videos related to
Sort By:
Page
of 16
Clinical Practice and Epidemiology in Mental Health : CP & EMH
|
December 9, 2010
Psychometric Attributes of the DISC Predictive Scales
Esther Cubo, Sara Sáez Velasco, Vanesa Delgado Benito, et al.
Journal of Parkinson'S Disease
|
January 2, 2022
Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel
Norbert Kovács, Lars Bergmann, Marieta Anca-Herschkovitsch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 8, 2005
Transcultural comparison of psychogenic movement disorders
Esther Cubo, Vanessa K Hinson, Christopher G Goetz, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
July 16, 2016
Spanish Validation of the Problem Behaviors Assessment-Short (PBA-s) for Huntington's Disease
Jesús M Ruiz-Idiago, Misericordia Floriach, Cèlia Mareca, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations
Tiago A Mestre, Monica Busse, Aileen M Davis, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 24, 2018
Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life
Tiago A Mestre, Noelle E Carlozzi, Aileen K Ho, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
June 21, 2022
Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington's disease
Miriam Saiz-Rodríguez, Cecilia Gil-Polo, Mónica Diez-Fairen, et al.
Movement Disorders Clinical Practice
|
October 11, 2021
DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease
David G Standaert, Jason Aldred, Marieta Anca-Herschkovitsch, et al.
Plos One
|
December 21, 2021
Adopting a multidisciplinary telemedicine intervention for fall prevention in Parkinson's disease. Protocol for a longitudinal, randomized clinical trial
Esther Cubo, Alvaro Garcia-Bustillo, Alvar Arnaiz-Gonzalez, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 15, 2016
Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations
Tiago A Mestre, Erik van Duijn, Aileen M Davis, et al.
Page
of 16